Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ethanol is a small molecule organic compound with the formula C2H5OH. It is a clear, colorless, volatile liquid with a characteristic odor and burning taste. Ethanol acts as a central nervous system depressant by enhancing the effect of gamma-aminobutyric acid (GABA) at GABA-A receptors and inhibiting excitatory neurotransmission via NMDA-type glutamate receptors. It is widely used as an ingredient in alcoholic beverages, as an industrial solvent, in pharmaceuticals (as an excipient or antiseptic), and as a biofuel additive to gasoline. Ethanol can be produced by fermentation of sugars using yeast or by chemical synthesis from ethylene[1][5]. In medicine, it is used topically as an antiseptic and disinfectant.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ethanol.